CompuGroup Financial Statements From 2010 to 2024

COP Stock   14.05  0.07  0.50%   
CompuGroup Medical financial statements provide useful quarterly and yearly information to potential CompuGroup Medical SE investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on CompuGroup Medical financial statements helps investors assess CompuGroup Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting CompuGroup Medical's valuation are summarized below:
CompuGroup Medical SE does not presently have any fundamental signals for analysis.
Check CompuGroup Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CompuGroup Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . CompuGroup financial statements analysis is a perfect complement when working with CompuGroup Medical Valuation or Volatility modules.
  
This module can also supplement various CompuGroup Medical Technical models . Check out the analysis of CompuGroup Medical Correlation against competitors.

CompuGroup Medical SE Company Operating Margin Analysis

CompuGroup Medical's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current CompuGroup Medical Operating Margin

    
  0.08 %  
Most of CompuGroup Medical's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CompuGroup Medical SE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, CompuGroup Medical SE has an Operating Margin of 0.0841%. This is 100.24% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The operating margin for all Germany stocks is 101.53% lower than that of the firm.

CompuGroup Medical Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining CompuGroup Medical's current stock value. Our valuation model uses many indicators to compare CompuGroup Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CompuGroup Medical competition to find correlations between indicators driving CompuGroup Medical's intrinsic value. More Info.
CompuGroup Medical SE is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.29  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CompuGroup Medical SE is roughly  3.49 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CompuGroup Medical's earnings, one of the primary drivers of an investment's value.

About CompuGroup Medical Financial Statements

CompuGroup Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although CompuGroup Medical investors may analyze each financial statement separately, they are all interrelated. The changes in CompuGroup Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on CompuGroup Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CompuGroup Stock Analysis

When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.